Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.

Saved in:
Bibliographic Details
Title: Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
Authors: Walsh RJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Ong R; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Cheo SW; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Low PQJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Jayagopal A; Department of Information Systems and Analytics, School of Computing, National University of Singapore, Singapore, Singapore., Lee M; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Ngoi N; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Ow SG; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Wong ALA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lim SE; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Lim YW; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Heong V; Department of Medical Oncology, Tan Tock Seng Hospital, Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore, Singapore., Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Chee CE; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Yong WP; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Tan DSP; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.; National University of Singapore (NUS) Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.
Source: Frontiers in oncology [Front Oncol] 2024 May 15; Vol. 14, pp. 1342346. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1342346